{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:59:56Z","timestamp":1794650396501,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.urolonc.2009.07.003","type":"journal-article","created":{"date-parts":[[2009,10,18]],"date-time":"2009-10-18T04:17:56Z","timestamp":1255839476000},"page":"508-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series"],"prefix":"10.1016","volume":"29","author":[{"given":"Derya","family":"Tilki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Schlenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majnu","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Buchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stanislaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"Erg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh K.","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2009.07.003_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","article-title":"EAU guidelines on prostate cancer","volume":"53","author":"Heidenreich","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1997.03540420041027","article-title":"Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathologic stage of localized prostate cancer","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2009.07.003_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.eururo.2005.11.007","article-title":"Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology","volume":"49","author":"Chun","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib4","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/cncr.22712","article-title":"Clinical predictors of Gleason score upgrading: Implications for patients considering watchful waiting, active surveillance, or brachytherapy","volume":"109","author":"Kulkarni","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.003_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1464-410X.2006.06262.x","article-title":"Significant upgrading affects a third of men diagnosed with prostate cancer: Predictive nomogram and internal validation","volume":"98","author":"Chun","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2009.07.003_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jnci\/djj190","article-title":"Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"98","author":"Stephenson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2009.07.003_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.juro.2007.10.060","article-title":"Prostate cancer volume at biopsy predicts clinically significant upgrading","volume":"179","author":"Dong","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib8","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1200\/JCO.2005.05.525","article-title":"Prostate size and risk of high-grade, advanced prostate cancer, and biochemical progression after radical prostatectomy: A search database study","volume":"23","author":"Freedland","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.urology.2006.10.036","article-title":"Upgrading and downgrading of prostate needle biopsy specimens: Risk factors and clinical implications","volume":"69","author":"Freedland","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.07.003_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1464-410X.2008.08059.x","article-title":"Prostate biopsy clinical and pathologic variables that predict significant grading changes in patients with intermediate and high grade prostate cancer","volume":"103","author":"Moussa","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2009.07.003_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(05)00236-3","article-title":"Evidence for a biopsy derived grade artifact among larger prostate glands","volume":"175","author":"Kulkarni","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.juro.2007.09.078","article-title":"Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: Results from the SEARCH database","volume":"179","author":"Turley","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.juro.2007.03.013","article-title":"Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies","volume":"178","author":"Kassouf","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.juro.2007.05.049","article-title":"Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy","volume":"178","author":"Sajadi","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1097-0096(199605)24:4<169::AID-JCU2>3.0.CO;2-D","article-title":"Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia","volume":"24","author":"Tewari","year":"1996","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.urolonc.2009.07.003_bib16","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2005.04.0756","article-title":"Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for a standardized definition","volume":"24","author":"Stephenson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/1097-0215(20001220)90:6<326::AID-IJC3>3.0.CO;2-J","article-title":"Prostate biopsy grading errors: A sampling problem?","volume":"90","author":"King","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2009.07.003_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.ju.0000132135.18093.d6","article-title":"Limitations of biopsy Gleason grade: Implications for counseling patients with biopsy Gleason score 6 prostate cancer","volume":"172","author":"Sved","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0022-5347(17)50583-2","article-title":"The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens","volume":"131","author":"Garnett","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib20","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.1200\/JCO.2005.03.3134","article-title":"Active surveillance for prostate cancer: For whom?","volume":"23","author":"Klotz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7\/SFUO-3): An open randomized phase III trial","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2009.07.003_bib22","first-page":"289","article-title":"Androgen suppression and radiation vs. radiation alone for prostate cancer: A randomized trial","volume":"299","author":"D'Amico","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2009.07.003_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2004.07.017","article-title":"Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy?","volume":"47","author":"Weckermann","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0360-3016(99)00260-6","article-title":"Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: Potential implications for patient selection for radiation and androgen suppression therapy","volume":"45","author":"D'Amico","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2009.07.003_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.urology.2007.05.022","article-title":"Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy","volume":"70","author":"Pierorazio","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.07.003_bib26","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1464-410X.2008.08015.x","article-title":"The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: Results from the Shared Equal Access Regional Cancer Hospital Database","volume":"102","author":"Turley","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2009.07.003_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijrobp.2003.10.014","article-title":"Extended prostate biopsy scheme improves reliability of Gleason grading: Implications for radiotherapy patients","volume":"59","author":"King","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2009.07.003_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.ju.0000074747.72993.cb","article-title":"Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: Role of prostate specific antigen density","volume":"170","author":"Allan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib29","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.juro.2008.08.027","article-title":"A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy\u2014can we predict adverse pathologic outcomes?","volume":"180","author":"Thong","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.003_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-5347(05)64051-7","article-title":"Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: Results of a community multi-practice study","volume":"169","author":"Presti","year":"2003","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814390900204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814390900204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:56:50Z","timestamp":1761040610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814390900204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S107814390900204X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2009.07.003","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2009.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}